Many PAH Patients Get Wrong Levels of Anti-clotting Agents, Study Finds

Anti-clotting agents can prevent pulmonary hypertension patients’ blood vessels from being blocked, but managing the agents can be challenging, a study reports.

In fact, it contends that managing them in a less than optimal way can lead to severe complications. The team defined less than optimal as prescribing too little or too much of the drugs to patients.

The study, “Assessment of the quality of anticoagulation management in patients with pulmonary arterial hypertension,” was published in the journal Thrombosis Research.

Clots can cause blood vessel lesions in pulmonary arterial hypertension patients, increasing the danger of blood vessels being blocked. To prevent clots, doctors prescribe anti-clotting drugs such as vitamin K antagonists.

The therapeutic tapestry the agents weave can be complex, however, with drug-diet interactions one of the dangers. The bottom line is that the agents can generate unpredictable responses.

Leave a Reply

Your email address will not be published. Required fields are marked *